Medical News Today previously reported on the research that Sarah Gilbert, a professor of vaccinology at Oxford University’s Jenner Institute in the United Kingdom, led on a potential vaccine.
The recombinant vaccine that the team developed uses a chimpanzee adenovirus (called ChAdOx1) that is harmless to humans, inserting into it the spike protein gene of SARS-CoV-2.As this approach to developing vaccines has been “extensively tested in other situations,” and the research group has a successful track record in this area (which includes developing a promising vaccine against MERS, a “cousin” of SARS), experts were hopeful a few months ago that Prof.